Brain Abscess
📧 Sign up to get email alerts when something new happens for Brain Abscess.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Circulating Cell-Free DNA for Brain Abscess Diagnosis: A Pilot Study [NA]
Pilot study evaluating circulating cell-free DNA for diagnosing brain abscess. The study is not yet recruiting and is sponsored by Universit…
-
CLINICAL_TRIALS research · 2025-07-04Clinical Trial Update: Cognitive Function and Fatigue After Brain Abscess
University of Oslo is recruiting for a clinical study to evaluate cognitive function and fatigue after a brain abscess.
-
CLINICAL_TRIALS trial_result · 2025-03-03Clinical Trial Update: BIGlobal Intervention Study: Improving Diagnosis and Management of Suspected Brain Infections Globally
The BIGlobal Intervention Study, which aims to improve diagnosis and management of suspected brain infections globally, has completed.
-
CLINICAL_TRIALS trial_result · 2025-01-30Clinical Trial Update: Partial Oral Antibiotic Treatment for Bacterial Brain Abscess [Phase 4]
This update describes a Phase 4 clinical trial evaluating a partial oral antibiotic regimen for bacterial brain abscesses, currently recruit…
-
FDA approval · 2024-10-25FDA Approved: METRONIDAZOLE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for metronidazole from Heritage Pharmaceuticals d/b/a Avet Pharmaceuticals Inc. under an ANDA.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-10-01Clinical Trial Update: Fosfomycin I.v. for Treatment of Severely Infected Patients
An intravenous fosfomycin trial is recruiting to evaluate its use in severely infected patients across multiple bacterial infection indicati…
-
FDA approval · 2024-06-18FDA Approved: METRONIDAZOLE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
The FDA approved a supplemental application for metronidazole from Heritage Pharmaceuticals Inc. (d/b/a Avet Pharmaceuticals Inc.) to modify…
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: Central Nervous System Infections in Denmark
A Danish clinical trial at Aalborg University Hospital is currently recruiting. It will study Central Nervous System infections, including m…
-
FDA approval · 2021-08-19FDA Approved: METRONIDAZOLE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
The FDA approved a supplemental application for METRONIDAZOLE submitted by Unichem Pharmaceuticals (USA), Inc., signaling an approved change…
-
CLINICAL_TRIALS research · 2016-01-01Clinical Trial Update: Biological Markers for the Diagnosis of Central Nervous System Infective Diseases
An update on a clinical trial researching biological markers to diagnose central nervous system infections such as meningitis and encephalit…
-
FDA approval · 2007-12-19FDA Approved: METRONIDAZOLE — Original Application (Cosette Pharmaceuticals, Inc.)
FDA approved Cosette Pharmaceuticals' original Abbreviated New Drug Application for metronidazole, enabling a generic version of this antimi…